Indu Parikh
Fondateur chez BioMarck Pharmaceuticals Ltd.
Profil
Dr. Indu Parikh is Chief Scientific Officer at BioMarck Pharmaceuticals Ltd.
Dr. Parikh was previously employed as a Principal by Burroughs Wellcome, Vice President by Glaxo, Inc., a Professor by Johns Hopkins Medicine, and Chief Scientific Officer by RTP Pharma, Inc.
He received his undergraduate degree from the University of Zurich.
Postes actifs de Indu Parikh
| Sociétés | Poste | Début |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Fondateur | 25/02/2002 |
Anciens postes connus de Indu Parikh
| Sociétés | Poste | Fin |
|---|---|---|
Johns Hopkins Medicine, Inc.
 Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
| Burroughs Wellcome | Corporate Officer/Principal | - |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Directeur Technique/Scientifique/R&D | - |
Formation de Indu Parikh
| University of Zurich | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
SkyePharma Canada, Inc.
SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Commercial Services |
| Glaxo, Inc. | |
| Burroughs Wellcome | |
Johns Hopkins Medicine, Inc.
Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD. | Health Services |